BUFFET JEAN-CHARLES (GB)
| WO1997015583A1 | 1997-05-01 |
| CLAIMS A compound of formula (I) shown below: wherein Ri is (1 -6C)alkyl, -Si(R2)3 or phenyl, either of which is optionally substituted with more groups selected from (1 -4C)alkyl; wherein each R2 is independently selected from (1 -3C)alkyl; Ra and Rb are independently hydrogen, (1 -6C)alkyl, aryl and aryl(1 -2C)alkyl, either or which may be optionally substituted with one or groups selected from (1 - 2C)alkyl; X is scandium, yttrium, lutetium, titanium, zirconium or hafnium each Y is independently halo, hydrogen, a phosphonated, sulfonated or borate anion, or a (1 -6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (1 -6C)alkoxy, aryl or aryloxy group which is optionally substituted with one or more groups selected from (1 -6C)alkyl, halo, nitro, amino, phenyl, (1 -6C)alkoxy, -C(0)NRxRy or Si[(1 -4C)alkyl]3; wherein Rx and Ry are independently (1 -4C)alkyl. The compound of claim 1 , wherein Ri is (1 -5C)alkyl, -Si(R2)3 or phenyl, either of which is optionally substituted with one or more groups selected from (1 -3C)alkyl, wherein each R2 is independently selected from (1 -4C)alkyl. The compound of claim 1 or 2, wherein Ri is (1 -5C)alkyl, -Si(R2)3 or phenyl, either of which is optionally substituted with one or more groups selected from (1 -3C)alkyl, wherein each R2 is independently selected from (1 -2C)alkyl. The compound of claim 1 , 2 or 3, wherein Ri is (2-5C)alkyl or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl. 5. The compound of claim 1 , wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, n-butyl, sec- butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl, di-isopropylphenyl, tert- butylphenyl or n-butylphenyl. 6. The compound of claim 1 , wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl or di-isopropylphenyl. 7. The compound of claim 1 , wherein Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted with a (1 -4C)alkyl group. 8. The compound of claim 1 , wherein Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted at the 4-position with n-butyl or tert-butyl. 9. The compound of claim 1 , wherein Ri is tert-butyl. 10. The compound of any preceding claim, wherein Ra and Rb are independently selected from hydrogen, (1 -4C)alkyl and phenyl. 1 1 . The compound of any preceding claim, wherein Ra and Rb are independently hydrogen or (1 -4C)alkyl. 12. The compound of any preceding claim, wherein Ra and Rb are independently selected from methyl, ethyl and propyl. 13. The compound of any preceding claim, wherein X is titanium, zirconium or hafnium. 14. The compound of any preceding claim, wherein X is titanium or zirconium. 15. The compound of any preceding claim, wherein X is titanium. 16. The compound of any preceding claim, wherein each Y is independently halo, hydrogen, or a (1 -4C)alkyl group which is optionally substituted with one or more groups selected from (1 -4C)alkyl, halo, nitro, amino, phenyl and (1 -4C)alkoxy. 17. The compound of any preceding claim, wherein each Y is independently halo, hydrogen, or a (1 -4C)alkyl group which is optionally substituted with one or more groups selected from (1 -4C)alkyl, halo and phenyl. 18. The compound of any preceding claim, wherein each Y is independently halo, hydrogen, or (1 -4C)alkyl. 19. The compound of any preceding claim, wherein one Y is chloro and the other is hydrogen or (1 -4C)alkyl. 20. The compound of any preceding claim, wherein each Y is independently halo. 21 . The compound of any preceding claim, wherein each Y is chloro. 22. The compound of any preceding claim, wherein the compound of formula (I) has a structure according to formula (la) below: (la) wherein Ra, Rt>, X, Y and Ri each have any of the definitions appearing in any preceding claim. 23. The compound of claim 22, wherein Y is chloro. 24. The compound of any preceding claim, wherein the compound of formula (I) has a structure according to formula (le) shown below: (le) wherein Ra and Rb are independently (1 -3C)alkyl. 25. The compound of any preceding claim, wherein the compound of formula (I) has any of the following structures: 26. A composition comprising a compound of formula (I) as defined in any preceding claim and: i. a support material; and/or ii. an activator. 27. The composition of claim 26, wherein the activator is an organo aluminium compound. 28. The composition of claim 26 or 27, wherein the support material is selected from silica, MAO-activated silica, layered-double hydroxide (LDH) and MAO-activated LDH. 29. The composition of claim 26, 27 or 28, wherein the LDH is an AMO-LDH, wherein AMO denotes an aqueous miscible organic solvent, a quantity of which is contained within the LDH structure. 30. The composition of any one of claims 26 to 29, wherein the activator is selected from methylaluminoxane, triisobutylaluminium, diethylaluminium and triethylaluminium. 31 . Use of a compound of formula (I) as claimed in any of claims 1 to 25 or a composition as defined in any of claims 26 to 30 in the polymerisation of ethylene and optionally one or more (3-10C)alkene. 32. The use of claim 31 , wherein ethylene and optionally one or more (3-10C)alkene are polymerised in the presence of hydrogen. 33. The use of claim 31 or 32, wherein the one or more (3-10C)alkene is 1 -hexene. 34. The use of claim 31 or 32, wherein the one or more (3-10C)alkene is styrene. 35. A polymerisation process comprising the step of: a) polymerising ethylene and optionally one or more (3-10C)alkene in the presence of a compound of formula (I) as claimed in any of claims 1 to 25 or a composition as defined in any of claims 26 to 30. 36. The process of claim 35, wherein step a) comprises polymerising ethylene and optionally one or more (3-10C)alkene in the presence of hydrogen. 37. The process of claim 35 or 36, wherein the one or more (3-10C)alkene is 1 -hexene. 38. The process of claim 35 or 36, wherein the one or more (3-10C)alkene is styrene. |
INTRODUCTION
[0001 ] The present invention relates to catalytic compounds. More particularly, the present invention relates to constrained geometry catalytic compounds, as well as catalytic compositions comprising the constrained geometry compounds associated with a support material. The present invention also relates to the use of catalytic compounds and compositions in the polymerisation of alkenes.
BACKGROUND OF THE INVENTION
[0002] It is well known that ethylene (and a-olefins in general) can be readily polymerized at low or medium pressures in the presence of certain transition metal catalysts. These catalysts are generally known as Zeigler-Natta type catalysts.
[0003] A particular group of these Ziegler-Natta type catalysts, which catalyse the polymerization of ethylene (and a-olefins in general), comprise an aluminoxane activator and a metallocene transition metal catalyst. Metallocenes comprise a metal bound between two η 5 - cyclopentadienyl type ligands. Generally the r -cyclopentadienyl type ligands are selected from rf-cyclopentadienyl, n, 5 -indenyl and n, 5 -fluorenyl.
[0004] At the time of their conception, constrained geometry complexes (CGCs) represented one of the first major departures from metallocene-based catalysts. In structural terms, CGCs feature a ττ-bonded ligand linked to one of the other ligands on the same metal centre, in such a manner that the angle subtended by the centroid of the ττ-system and the other ligand from the metal centre is smaller than in comparable complexes wherein the ττ-bonded ligand and the other ligand are not linked. To date, research in the field of CGCs has centred around ansa- bridged cyclopentadienyl amido complexes, with such catalysts presently featuring heavily in the industrial preparation of CGC-derived polymers.
[0005] In spite of the advances made using ansa-bridged cyclopentadienyl amido-based complexes, there remains a need for CGCs having improved characteristics. In particular, there remains a need for CGCs having improved catalytic properties and/or GCGs suitable for preparing polymers having desirable characteristics. Such improved catalytic properties may include enhanced catalytic activity, better co-monomer incorporation and improved stability. Desirable polymer characteristics may include particular polymer molecular weights, polydispersities and melt indices. [0006] The present invention was devised with the foregoing in mind.
SUMMARY OF THE INVENTION
[0007] According to a first aspect of the present invention, there is provided a compound of formula (I) as defined herein.
[0008] According to a further aspect of the present invention, there is provided a composition comprising a compound of formula (I) as defined herein and:
i. a support material; and/or
ii. an activator.
[0009] According to a further aspect of the present invention, there is provided a use of a compound of formula (I) defined herein or composition as defined herein in the polymerisation of ethylene and optionally one or more (3-10C)alkene.
[0010] According to a further aspect of the present invention, there is provided a polymerisation process comprising the step of:
a) polymerising ethylene and optionally one or more (3-10C)alkene in the presence of a compound of formula (I) defined herein or a composition as defined herein.
DETAILED DESCRIPTION OF THE INVENTION
Definitions
[0011 ] The term "(m-nC)" or "(m-nC) group" used alone or as a prefix, refers to any group having m to n carbon atoms.
[0012] The term "alkyl" as used herein includes reference to a straight or branched chain alkyl moieties, typically having 1 , 2, 3, 4, 5 or 6 carbon atoms. This term includes reference to groups such as methyl, ethyl, propyl (n-propyl or isopropyl), butyl (n-butyl, sec-butyl or tert- butyl), pentyl (including neopentyl), hexyl and the like. In particular, an alkyl may have 1 , 2, 3 or 4 carbon atoms.
[0013] The term "alkenyl" as used herein include reference to straight or branched chain alkenyl moieties, typically having 2, 3, 4, 5 or 6 carbon atoms. The term includes reference to alkenyl moieties containing 1 , 2 or 3 carbon-carbon double bonds (C=C). This term includes reference to groups such as ethenyl (vinyl), propenyl (allyl), butenyl, pentenyl and hexenyl, as well as both the cis and trans isomers thereof. [0014] The term "(3-10C)alkene" as used herein includes reference to any alkene having 3-10 carbon atoms that is capable of being copolymerised with ethylene. Straight and branching aliphatic alkenes are included (e.g. 1 -hexene or 1 -octene), as are alkenes comprising an aromatic moiety (e.g. styrene).
[0015] The term "alkynyl" as used herein include reference to straight or branched chain alkynyl moieties, typically having 2, 3, 4, 5 or 6 carbon atoms. The term includes reference to alkynyl moieties containing 1 , 2 or 3 carbon-carbon triple bonds (C≡C). This term includes reference to groups such as ethynyl, propynyl, butynyl, pentynyl and hexynyl.
[0016] The term "alkoxy" as used herein include reference to -O-alkyl, wherein alkyl is straight or branched chain and comprises 1 , 2, 3, 4, 5 or 6 carbon atoms. In one class of embodiments, alkoxy has 1 , 2, 3 or 4 carbon atoms. This term includes reference to groups such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentoxy, hexoxy and the like.
[0017] The term "aryl" as used herein includes reference to an aromatic ring system comprising 6, 7, 8, 9 or 10 ring carbon atoms. Aryl is often phenyl but may be a polycyclic ring system, having two or more rings, at least one of which is aromatic. This term includes reference to groups such as phenyl, naphthyl and the like.
[0018] The term "aryl(m-nC)alkyl" means an aryl group covalently attached to a (m- nC)alkylene group. Examples of aryl-(m-nC)alkyl groups include benzyl, phenylethyl, and the like.
[0019] The term "halogen" or "halo" as used herein includes reference to F, CI, Br or I. In a particular, halogen may be F or CI, of which CI is more common.
[0020] The term "substituted" as used herein in reference to a moiety means that one or more, especially up to 5, more especially 1 , 2 or 3, of the hydrogen atoms in said moiety are replaced independently of each other by the corresponding number of the described substituents. The term "optionally substituted" as used herein means substituted or unsubstituted.
[0021 ] It will, of course, be understood that substituents are only at positions where they are chemically possible, the person skilled in the art being able to decide (either experimentally or theoretically) without inappropriate effort whether a particular substitution is possible. For example, amino or hydroxy groups with free hydrogen may be unstable if bound to carbon atoms with unsaturated (e.g. olefinic) bonds. Additionally, it will of course be understood that the substituents described herein may themselves be substituted by any substituent, subject to the aforementioned restriction to appropriate substitutions as recognised by the skilled person. Compounds of the invention
[0022] As described hereinbefore, the present invention provides a compound of formula (I) shown below:
Ri is (1 -6C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more groups selected from (1 -4C)alkyl;
wherein each R 2 is independently selected from (1 -3C)alkyl;
R a and Rb are independently hydrogen, (1 -6C)alkyl, aryl and aryl(1 -2C)alkyl, either or which may be optionally substituted with one or groups selected from (1 - 2C)alkyl;
X is scandium, yttrium, lutetium, titanium, zirconium or hafnium
each Y is independently halo, hydrogen, a phosphonated, sulfonated or borate anion, or a (1 -6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (1 -6C)alkoxy, aryl or aryloxy group which is optionally substituted with one or more groups selected from (1 -6C)alkyl, halo, nitro, amino, phenyl, (1 -6C)alkoxy, -C(0)NR x R y or -Si[(1 -4C)alkyl] 3 ;
wherein R x and R y are independently (1 -4C)alkyl.
[0023] The compounds of the invention offer a number of advantages when compared with CGCs currently favoured by industry. In particular, the compounds of the invention have been shown to be as much as twelve times more catalytically active in the homopolymerisation of ethylene than the ansa-bridged cyclopentadienyl amido CGC currently preferred in industry.
[0024] In an embodiment, Ri is (1 -5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more groups selected from (1 -3C)alkyl, wherein each R 2 is independently selected from (1 -4C)alkyl.
[0025] In another embodiment, Ri is (1 -5C)alkyl, -Si(R 2 ) 3 or phenyl, either of which is optionally substituted with one or more groups selected from (1 -3C)alkyl, wherein each R 2 is independently selected from (1 -3C)alkyl. [0026] In another embodiment, Ri is (2-5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl, wherein each R 2 is independently selected from (1 -2C)alkyl.
[0027] In another embodiment, Ri is (2-5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -3C)alkyl, wherein each R 2 is independently selected from (1 -2C)alkyl.
[0028] In another embodiment, Ri is (2-5C)alkyl or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl.
[0029] In another embodiment, Ri is (2-5C)alkyl or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (2-4C)alkyl.
[0030] In another embodiment, Ri is methyl, ethyl, iso-propyl, iso-butyl, n-butyl, sec-butyl, tert- butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl, di-isopropylphenyl, tert-butylphenyl or n- butylphenyl.
[0031 ] In another embodiment, Ri is methyl, ethyl, iso-propyl, iso-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl or di-isopropylphenyl.
[0032] In another embodiment, Ri is (1 -5C)alkyl.
[0033] In a particularly suitable embodiment, Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted with a (1 -4C)alkyl group.
[0034] In a particularly suitable embodiment, Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted at the 4-position with a (1 -4C)alkyl group.
[0035] In a particularly suitable embodiment, Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted at the 4-position with n-butyl or tert-butyl.
[0036] In a particularly suitable embodiment, Ri is tert-butyl or iso-propyl.
[0037] In a particularly suitable embodiment, Ri is tert-butyl.
[0038] In another embodiment, R a and Rb are independently selected from hydrogen, (1 - 4C)alkyl, phenyl and benzyl.
[0039] In another embodiment, R a and Rb are independently selected from hydrogen, (1 - 3C)alkyl, phenyl and benzyl.
[0040] In another embodiment, R a and Rb are independently selected from hydrogen or (1 - 3C)alkyl.
[0041 ] In another embodiment, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl. [0042] In another embodiment, X is titanium, zirconium or hafnium. Suitably, X is zirconium or titanium. More suitably, X is titanium
[0043] In another embodiment, each Y is independently halo, hydrogen, or a (1 -4C)alkyl group which is optionally substituted with one or more groups selected from (1 -4C)alkyl, halo, nitro, amino, phenyl and (1 -4C)alkoxy.
[0044] In another embodiment, each Y is independently halo, hydrogen, or a (1 -4C)alkyl group which is optionally substituted with one or more groups selected from (1 -4C)alkyl, halo and phenyl.
[0045] In another embodiment, each Y is independently halo, hydrogen, or (1 -4C)alkyl.
[0046] In another embodiment, each Y is independently halo. Suitably, at least one Y group is chloro. More suitably, both Y groups are chloro.
[0047] In an embodiment, the compound of formula (I) has a structure according to formula (la) below:
(la)
wherein
Ri , R a , Rb, X and Y are each independently as defined in any of the paragraphs provided hereinbefore.
[0048] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein Ri is (2-5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl, wherein each R 2 is independently selected from (1 -2C)alkyl.
[0049] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, n-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl, di-isopropylphenyl, tert-butylphenyl or n- butylphenyl. [0050] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl or di-isopropylphenyl. Suitably, Ri is methyl, ethyl, iso- propyl, iso-butyl, sec-butyl, tert-butyl or neopentyl. Even more suitably, Ri is tert-butyl.
[0051 ] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted with a (1 -4C)alkyl group.
[0052] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein R a and Rb are independently selected from hydrogen or (1 -3C)alkyl. Suitably, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl.
[0053] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein X is titanium or zirconium.
[0054] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein X is titanium.
[0055] In another embodiment, the compound of formula (I) has a structure according to formula (la), wherein each Y is independently halo, hydrogen, or (1 -4C)alkyl.
[0056] In an embodiment, the compound of formula (I) has a structure according to formula (lb) below:
wherein
Ri , R a , Rb and X are as defined in any of the paragraphs provided hereinbefore.
[0057] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein Ri is (2-5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl, wherein each R 2 is independently selected from (1 -2C)alkyl. [0058] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, n-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl, di-isopropylphenyl, tert-butylphenyl or n- butylphenyl.
[0059] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl or di-isopropylphenyl. Suitably, Ri is methyl, ethyl, iso- propyl, iso-butyl, sec-butyl, tert-butyl or neopentyl. Even more suitably, Ri is tert-butyl.
[0060] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted with a (1 -4C)alkyl group.
[0061 ] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein R a and Rb are independently selected from hydrogen or (1 -3C)alkyl. Suitably, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl.
[0062] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein X is titanium or zirconium.
[0063] In another embodiment, the compound of formula (I) has a structure according to formula (lb), wherein X is titanium.
[0064] In an embodiment, the compound of formula (I) has a structure according to formula (lc) below:
(lc)
wherein
Ri , R a , Rb and Y are each independently as defined in any of the paragraphs provided hereinbefore. [0065] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein Ri is (2-5C)alkyl, -Si(R 2 )3 or phenyl, either of which is optionally substituted with one or more (e.g. 2 or 3) groups selected from (1 -4C)alkyl, wherein each R 2 is independently selected from (1 -2C)alkyl.
[0066] n another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, n-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl, di-isopropylphenyl, tert-butylphenyl or n- butylphenyl.
[0067] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein Ri is methyl, ethyl, iso-propyl, iso-butyl, sec-butyl, tert-butyl, neopentyl, trimethylsilyl, phenyl, mesityl, xylyl or di-isopropylphenyl. Suitably, Ri is methyl, ethyl, iso- propyl, iso-butyl, sec-butyl, tert-butyl or neopentyl. Even more suitably, Ri is tert-butyl.
[0068] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein Ri is n-butyl, tert-butyl, iso-propyl, or phenyl substituted with a (1 -4C)alkyl group.
[0069] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein R a and Rb are independently selected from hydrogen or (1 -3C)alkyl. Suitably, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl.
[0070] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein each Y is independently halo, hydrogen, or (1 -4C)alkyl.
[0071 ] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein each Y is independently halo. Suitably, at least one Y group is chloro. More suitably, both Y groups are chloro.
[0072] In another embodiment, the compound of formula (I) has a structure according to formula (Ic), wherein at least one Y group is chloro and the other is (1 -4C)alkyl.
[0073] In an embodiment, the compound of formula (I) has a structure according to formula (Id) below:
wherein
R a , Rb and Y are each independently as defined in any of the paragraphs provided hereinbefore.
[0074] In another embodiment, the compound of formula (I) has a structure according to formula (Id), wherein R a and Rb are independently selected from hydrogen or (1 -3C)alkyl. Suitably, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl.
[0075] In another embodiment, the compound of formula (I) has a structure according to formula (Id), each Y is independently halo, hydrogen, or (1 -4C)alkyl.
[0076] In another embodiment, the compound of formula (I) has a structure according to formula (Id), wherein each Y is independently halo. Suitably, at least one Y group is chloro. More suitably, both Y groups are chloro.
[0077] In another embodiment, the compound of formula (I) has a structure according to formula (Id), wherein at least one Y group is chloro and the other is (1 -4C)alkyl.
[0078] In an embodiment, the compound of formula (I) has a structure according to formula (le) below:
wherein R a and Rb are each independently as defined in any of the paragraphs provided hereinbefore.
[0079] In another embodiment, the compound of formula (I) has a structure according to formula (le), wherein R a and Rb are independently selected from hydrogen or (1 -3C)alkyl. Suitably, R a and Rb are both methyl or ethyl, or one of R a and Rb is methyl and the other is propyl.
[0080] In a particularly suitable embodiment, the compound of formula (I) has any of the following structures:
[0081 ] In a particularly suitable embodiment, the compound of formula (I) has any of the following structures:
Compositions of the invention
[0082] As described hereinbefore, the present invention also provides a composition comprising a compound of formula (I) as defined herein and:
i. a support material; and/or
ii. an activator.
[0083] The compounds of the invention may be used in homogeneous, solution phase polymerisation reactions. When intended for use in homogeneous, solution phase polymerisation reactions, the compound of formula (I) may be used alongside an activator, such that the compound of formula (I) and the activator form a catalytic composition of the invention.
[0084] It will be appreciated that any suitable activator known in the art may be used. Activators may also be known in the art as co-catalysts. Suitable activators include organo aluminium compounds (e.g. alkyl aluminium compounds). Suitably, the activator is selected from aluminoxanes (e.g. methylaluminoxane (MAO)), triisobutylaluminium (TIBA), diethylaluminium (DEAC) and triethylaluminium (TEA). One or more activators may be used. The activator may also serve the purpose of scavenging moisture and/or oxygen.
[0085] The compounds of the invention may also be used in heterogeneous, slurry phase polymerisation reactions. When intended for use in homogeneous, solution phase polymerisation reactions, the compound of formula (I) is associated with a support material. The support material is insoluble under the polymerisation reaction conditions. The compound of the invention, when associated with a support material, forms a catalytic composition of the invention. [0086] The compound of formula (I) may be associated with the support material by one or more ionic or covalent interactions. It will be understood that any minor structural modifications to the compound of formula (I) arising from it being associated with the support material are within the scope of this invention. For example, and without wishing to be bound by theory, the compound of formula (I) may be associated with the support material by one or more bonds from X to the surface of the support material (which may result in the loss of one or more Y groups).
[0087] In an embodiment, the support material is selected from silicas, layered-double hydroxides (LDH, e.g. AMO-LDH MgAI-C03, wherein "AMO" is an aqueous miscible organic solvent, a quantity of which is comprised within the LDH structure), and any other inorganic support material. Supports such as silica and AMO-LDH may be subjected to a heat treatment prior to use. An exemplary heat treatment involves heating the support to 400-600 °C (for silicas) or 100-150 °C (for AMO-LDHs) in a nitrogen atmosphere.
[0088] In another embodiment, the support material may be an activated support material. The support may be activated by the presence of a suitable activator being covalently bound to the support. Suitable activators include organo aluminium compounds (e.g. alkyl aluminium compounds), in particular methylaluminoxane. Examples of activated supports include methylaluminoxane activated silica and methylaluminoxane activated layered double hydroxide.
[0089] In another embodiment, the support material is an activated support material (e.g. MAO- activated silica), and the activator is selected from aluminoxanes (e.g. methylaluminoxane (MAO)), triisobutylaluminium (TIBA), diethylaluminium (DEAC) and triethylaluminium (TEA).
[0090] In an embodiment, the mole ratio of solid support to the compound of formula (I) is 50:1 to 500:1 . Suitably, the mole ratio of solid support to the compound of formula (I) is 75:1 to 400:1 . More suitably, the mole ratio of solid support to the compound of formula (I) is 100:1 to 300:1 .
Preparation of compounds of invention
[0091 ] The compounds of formula (I) may be synthesised by any suitable process known in the art. Particular examples of processes for the preparation compounds of the present invention are set out in the accompanying examples.
[0092] Suitably, a compound of the present invention is prepared by:
(i) reacting a compound of formula A:
A
(wherein Ri , R a and Rb are each as defined hereinbefore and M is Li, Na or K) with a compound of the formula B:
X(Y') 4
B
(wherein X is as defined hereinbefore and Y' is halo (particularly chloro or bromo)) in the presence of a suitable solvent to form a compound of formula (Γ):
and optionally thereafter:
(ii) reacting the compound of formula la above with MY" (wherein M is as defined above and Y" is a group Y as defined herein other than halo), in the presence of a suitable solvent to form the compound of the formula (I") shown below
(I")
[0093] Suitably, M is Li in step (i) of the process defined above.
[0094] Suitably, the compound of formula B is provided as a solvate. In particular, the compound of formula B may be provided as X(Y') 4 .THFp, where p is an integer (e.g. 2).
[0095] Any suitable solvent may be used for step (i) of the process defined above. A particularly suitable solvent is toluene or THF.
[0096] If a compound of formula (I) in which Y is other than halo is required, then the compound of formula (Γ) above may be further reacted in the manner defined in step (ii) to provide a compound of formula (I").
[0097] Any suitable solvent may be used for step (ii) of the process defined above. A suitable solvent may be, for example, diethyl ether, toluene, THF, dichloromethane, chloroform, hexane DMF, benzene etc.
[0098] Compounds of formula A may generally be prepared by:
(i) Reacting a compound of formula C:
C
(wherein M is lithium, sodium, or potassium) with one equivalent of a compound having formula D shown below: Si(Ra)(Rb)(CI) 2 D
(wherein R a and Rb are as defined hereinbefore)
to form the compound of the formula E shown below:
E
(ii) Reacting the compound of formula E with a compound of formula F shown below:
R N(H)Li
F
(wherein Ri is as defined hereinbefore, and wherein Li may be substituted for K or Na).
[0099] Compounds of formulae A and F can be readily synthesised by techniques well known in the art.
[00100] Any suitable solvent may be used for step (i) of the above process. A particularly suitable solvent is THF.
[00101] Similarly, any suitable solvent may be used for step (ii) of the above process. A suitable solvent may be, for example, toluene, THF, DMF etc.
[00102] A person of skill in the art will be able to select suitable reaction conditions (e.g. temperature, pressures, reaction times, agitation etc.) for such a synthesis.
[00103] Once prepared, the compound of formula (I) may be associated with a support material by any suitable means known in the art. For example, the compound of formula (I) may be associated with a support material (e.g. Si0 2 , MAO-activated Si0 2 (SSMAO) or MAO- activated LDH (LDHMAO)) by contacting the compound of formula (I) with the support material in a suitable solvent (e.g. toluene) with optional heating, and then isolating the resulting solid. Uses of the compounds and compositions
[00104] As described hereinbefore, the present invention also provides a use of a compound of formula (I) defined herein or a composition as defined herein in the polymerisation of ethylene and optionally one or more (3-10C)alkene.
[00105] The compounds and compositions of the invention may be used as catalysts in the preparation of a variety of polymers, including polyalkylenes (e.g. polyethylene) of varying molecular weight, and copolymers. Such polymers and copolymers may be prepared by homogeneous solution-phase polymerisation of a monomer-containing feed stream (e.g. using the compounds of the invention), or heterogeneous slurry-phase polymerisation of a monomer- containing feed stream (e.g. using the compositions of the invention).
[00106] In an embodiment, when the optional one or more (3-10C)alkene is not included, the compounds and compositions of the invention may be used to prepare polyethylene homopolymers. Suitably, the one or more (3-10C)alkene is an a-olefin.
[00107] In another embodiment, the optional one or more (3-10C)alkene is one or more (3-8C)alkene. Suitably, the quantity of the one or more (3-8C)alkene in the monomer feed stream is 0.05-10 mol%, relative to the quantity of ethylene monomers. More suitably, the one or more (3-8C)alkene is selected from 1 -hexene, 1 -octene and styrene. Hence, the compounds and compositions of the present invention are useful as catalysts in the preparation of copolymers such as poly(ethylene-co-hexene), poly(ethylene-co-octene) and poly(ethylene-co- styrene).
[00108] In a particularly suitable embodiment, the compounds and compositions of the invention are used to copolymerise ethylene and styrene.
[00109] In a particularly suitable embodiment, the compounds and compositions of the invention are used to copolymerise ethylene and 1 -hexene
[00110] In another embodiment, in addition to ethylene and the optional one or more (3- 10C)alkene, the polymerisation is also conducted in the presence of hydrogen. Hydrogen acts to control the molecular weight of the growing polymer or copolymer. When hydrogen is used alongside ethylene and the optional one or more (3-10C)alkene in the feed stream, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.5:1 . Suitably, when hydrogen is used alongside ethylene and the optional one or more (3-10C)alkene, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.1 :1 . More suitably, when hydrogen is used alongside ethylene and the optional one or more (3-10C)alkene, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.05:1 . [00111] As described hereinbefore, the present invention also provides a polymerisation process comprising the step of:
a) polymerising ethylene and optionally one or more (3-10C)alkene in the presence of a compound of formula (I) defined herein or composition as defined herein.
[00112] The compounds and compositions of the invention may be used as catalysts in the preparation of a variety of polymers, including polyalkylenes (e.g. polyethylene) of varying molecular weight, and copolymers. Such polymers and copolymers may be prepared by homogeneous solution-phase polymerisation of a monomer-containing feed stream (e.g. using the compounds of the invention), or heterogeneous slurry-phase polymerisation of a monomer- containing feed stream (e.g. using the compositions of the invention).
[00113] In an embodiment, step a) is conducted at a temperature of 30-120 °C. Suitably, step a) is conducted at a temperature of 40-80 °C.
[00114] In another embodiment, step a) is conducted at a pressure of 1 -10 bar.
[00115] In another embodiment, step a) is conducted in a suitable solvent (e.g. aromatics, including toluene, and/or alkanes, including hexanes or heptane).
[00116] In another embodiment, step a) may be conducted for between 1 minute and 5 hours. Suitably, step a) may be conducted for between 5 minutes and 2 hours.
[00117] In another embodiment, when the optional one or more (3-10C)alkene is not included, the process yields polyethylene homopolymer.
[00118] In another embodiment, the optional one or more (3-10C)alkene (which may be an a-olefin) is one or more (3-8C)alkene. Suitably, the quantity of the one or more (3-8C)alkene in the monomer feed stream is 0.05-10 mol%, relative to the quantity of ethylene monomers. More suitably, the one or more (3-8C)alkene is selected from 1 -hexene, 1 -octene and styrene. Hence, the process may be used to prepare copolymers such as poly(ethylene-co-hexene), poly(ethylene-co-octene) and poly(ethylene-co-styrene).
[00119] In a particularly suitable embodiment, step a) comprises polymerising ethylene and styrene in the presence of a compound of formula (I) defined herein or composition as defined herein.
[00120] In a particularly suitable embodiment, step a) comprises polymerising ethylene and 1 -hexene in the presence of a compound of formula (I) defined herein or composition as defined herein
[00121] In another embodiment, in addition to ethylene and the optional one or more (3- 10C)alkene, the polymerisation is also conducted in the presence of hydrogen. Hydrogen acts to control the molecular weight of the growing polymer or copolymer. When hydrogen is used alongside ethylene and the optional one or more (3-10C)alkene in the feed stream, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.5:1 . Suitably, when hydrogen is used alongside ethylene and the optional one or more (3-1 0C)alkene, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.1 :1 . More suitably, when hydrogen is used alongside ethylene and the optional one or more (3-1 0C)alkene, the mole ratio of hydrogen to total alkenes in the feed stream is 0.001 :1 to 0.05:1 .
EXAMPLES
[00122] Particular examples of the invention will now be described, for the purpose of illustration only, with reference to the accompanying figures, in which :
Fig. 1 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( tBu N,l*)H 2 .
Fig. 2 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Με · ΡΓ °ρ>"8Β(< Βυ Ν, Γ)Η 2 .
Fig. 3 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( tBu N,l*)TiCI 2 .
Fig. 4 shows the 1 H NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Et2 SB( tBu N, l*)TiCI 2 .
Fig. 5 shows the molecular structure of Me2 SB( tBu N,l*)TiCI 2 .
Fig. 6 compares the catalytic activity of the Et2 SB( tBu N, )TiCI 2 constrained geometry compound of the invention with that of the Me 2SB(' Bu N,Cp*)TiCI 2 comparator compound when used in the solution phase polymerisation of ethylene. Polymerisation conditions: 2 bar ethylene, 50 ml_ hexanes, 40 mg MAO.
Fig. 7 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( iPr N,l*)H 2 .
Fig. 8 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( nBu N,l*)H 2 .
Fig. 9 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( 4tBuPh N, l*)H 2 .
Fig. 10 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( 4nBuPh N, l*)H 2 . Fig. 1 1 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( iPr N, l*)TiCI 2 .
Fig. 12 shows the Ή NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( nBu N, l*)TiCI 2 . Fig. 13 shows the 1 H NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( 4tBuPh N,l*)TiCI 2 . Fig. 14 shows the 1 H NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( 4nBuPh N, l*)TiCI 2 . Fig. 15 shows the 1 H NMR spectrum (400 MHz, benzene-cfe, 23 °C) of Me2 SB( tBu N, l*)ZrCI 2 .
Fig. 16 shows the molecular structure of Me2 SB( iPr N,l*)TiCI 2 . Fig. 17 shows the molecular structure of Me2 SB( tBuPh N,l * )TiCI 2 .
Fig. 18 compares the catalytic activity of the LDHMAO- Et2 SB( tBu N,l * )TiCI 2 constrained geometry complex composition of the invention with that of the LDHMAO- Me2 SB( tBu N,Cp * )TiCI 2 comparator composition in the slurry phase polymerisation of ethylene. Polymerisation conditions: 2 bar ethylene, 50 mL hexanes, 150 mg TIBA, 70 °C, 30 minutes.
Fig. 19 shows the SEM images of polyethylene synthesised using the LDHMAO- Et 2SB( tBu N,l * )TiCl2 constrained geometry complex composition of the invention and the LDHMAO- Me2 SB( tBu N,Cp * )TiCl2 comparator composition in the slurry phase polymerisation of ethylene. Polymerisation conditions: 2 bar ethylene, 50 mL hexanes, 150 mg TIBA, 70 °C, 30 minutes.
Fig. 20 shows scale up solution polymerisation of ethylene using Me2 SB( tBu N,l * )TiCl2. Polymerisation conditions: 5 bar ethylene, 1500 mL hexanes, 70 °C, 30-60 minutes, 3-7 mg of Me2 SB( tBu N,l * )TiCI 2 .
Example 1 - Synthesis of silyl-bridqedf(permethylindenyl)(t-butyl amido)titanium dichloride ( R2 SB( tBu N *)TiCI 2 ) CGCs
[00123] Having regard to Scheme 1 shown below, ligands useful in the preparation of the R2 SB( tBu N, )TiCI 2 CGCs were synthesised by the following procedure: In a large Schlenk, 1 equivalent of greenish oil hexamethylindene (lnd # )H (3.0 g, 15.0 mmol) was dissolved in 100 mL pentane to afford a greenish solution. 1 .1 equivalent of "BuLi (1 1 .0 mL, 16.4 mmol, 2.5 M in Hexanes) was added dropwise (over 30 minutes) unto the previous solution cooled to 5 °C (ice/water bath). The solution turned slightly yellow/ green. The reaction was left stirring at 23 °C for 18 h. After 18 h, the Schlenk contains off-white solid ((lnd # )Li) and dark orange solution. The pentane was pumped away to afford off-white solid. THF (30 mL) was added unto the solid to afford a red solution, then this solution was added dropwise (over 15 minutes) unto a previously cooled (to 5 °C) solution of 3.0 equivalent of dichlorodimethylsilane (5.8 g, 5.5 mL, 44.9 mmol) in THF (20 mL) or other dichlorodialkylsilane. The red solution of (lnd # )Li instantly decolourised when reacting with the previous solution. After 15 minutes, the yellow solution was stirred for 2 h at 23 °C. Then, the THF was dried to afford lnd * SiMe2CI as an oil. Finally, 1 .1 equivalent of LiNH'Bu (1 .3 g, 16.4 mmol) in THF (20 mL) was added at once unto a solution of lnd * SiMe 2 CI in THF (40 mL) cooled at to 5 °C (ice/water bath). The solution was stirred for 18 h, then dried, extracted with 2 χ 20 mL of pentane and finally dried to afford Me2 Si( tBu N,l * )H 2 as an oil in quantitative yield.
Scheme 1 - Preparation of R2 SB( tBu NJ*)Hp liqand from lnd*SiR?CI
[00124] Figures 1 and 2 respectively show the Ή NMR spectra for the ligands Me2 SB( tBu N,r)H 2 and Me - Pra py'SB( tBu N,r)H2.
[00125] Once the R2 SB( tBu N,l*)H 2 ligand has been prepared, the R2 SB( tBu N, l*)TiCI 2 CGCs were formed according to Scheme 2 shown below by the following procedure: 2.2 equivalents of "BuLi (2.7 ml_, 6.7 mmol, 2.5 M in hexanes) was added dropwise, over 5 minutes, unto a solution of 1 equivalent of Me2 Si( tBu N,l*)H 2 (1 g, 3.0 mmol) in THF (40 mL) cooled to 5 °C. The solution quickly turned red. The reaction was stirred for 2 h at 25 °C. Then the solvent was dried and the sticky orange solid was washed with 2 χ 50 mL of pentane to afford a yellow solid in quantitative yields. Benzene (40 mL) was added into a Schlenk containing 1 equivalent of Me2 Si( tBu N,l*)Li 2 (1 g, 2.9 mmol) and 1 equivalent of TiCI 4 .THF 2 (978 mg, 2.9 mmol), the solution turned dark red. The reaction was stirred for 17 h at 25 °C. Then, the solution was thoroughly dried and the dark red solid was extracted with 2 χ 50 mL pentane. The pentane solution was concentrated to 20 mL and put in -30 °C freezer. A 1 st crop of Me2 Si( tBu N,l*)TiCI 2 was isolated in 26% yield (335 mg), the solution was put back in a -30 °C freezer.
Scheme 2 - Preparation of R2 SB( tBu N.r)TiCI ? ) CGCs from R2 SB( tBu N.r)H ? [00126] Figures 3 and 4 respectively show the 1 H NMR spectra for the CGCs Me2 SB( tBu N,l * )TiCI 2 and Et2 SB( tBu N,l * )TiCI 2 . Figure 5 shows the molecular structure of Me2 SB( tBu N,r)TiCI 2 .
Example 2 - Polymerisation studies
Ethylene homopolymerisation
[00127] The catalytic activity of the Et2 SB( tBu N,r)TiCI 2 compound of the invention in the solution-phase homopolymerisation of ethylene was compared with that of the commercially- available ansa-bridged permethylcyclopentadienyl amido CGC shown below:
[00128] The results are provided in Table 1 below, as well as in Figure 6.
Table 1. Solution phase polymerisation using unsymmetrical ( Et2 SB( Bu N,l * )TiCI 2 ) and commercial constrained geometry complexes ( Me2 SB( Bu N,Cp * )TiCI 2 ).
Polymerisation conditions: 2 bar ethylene, 50 mL hexanes, 40 mg MAO.
[00129] Table 1 and Figure 6 show that the Et2 SB( tBu N,l * )TiCI 2 compound of the invention was more than twice as active as the ansa-bridged permethylcyclopentadienyl amido CGC currently favoured by industry over the course of a 120 second polymerisation reaction. Moreover, the Et2 SB( tBu N,l * )TiCl2 compound of the invention was more than twelve times as active as the comparator compound when the duration of the polymerisation reaction was increased to 600 seconds.
Example 3 - Synthesis of dimethylsilyl-bridqed[(permethylindenyl)(R amido)titanium dichloride ( Me2 SB( R N.I*)TiCI 2 ) CGCs
[00130] With regard to Scheme 3 shown below, ligands useful in the preparation of the Me2 SB( R N, )TiCI 2 GCGs were synthesised by the following procedure: In a large Schlenk, 1 equivalent of greenish oil hexamethylindene (lnd # )H (3.0 g, 15.0 mmol) was dissolved in 100 mL pentane to afford a greenish solution. 1 .1 equivalent of "BuLi (1 1 .0 mL, 16.4 mmol, 2.5 M in hexanes) was added dropwise (over 30 minutes) unto the previous solution cooled to 5 °C (ice/water bath). The solution turned slightly yellow/ green. The reaction was left stirring at 23 °C for 18 h. After 18 h, the Schlenk contains off-white solid ((lnd # )Li) and dark orange solution. The pentane was pumped away to afford off-white solid. THF (30 mL) was added unto the solid to afford a red solution, then this solution was added dropwise (over 15 minutes) unto a previously cooled (to 5 °C) solution of 3.0 equivalent of dichlorodimethylsilane (5.8 g, 5.5 mL, 44.9 mmol) in THF (20 mL). The red solution of (lnd # )Li instantly decolourised when reacting with the previous solution. After 15 minutes, the yellow solution was stirred for 2 h at 23 °C. Then, the THF was dried to afford lnd * SiMe 2 CI as an oil. 1 equivalent of RNHLi (R = Vr (0.21 g), n Bu (0.27 g), 4-'BuPh (0.50 g), and 4- n BuPh (0.50 g)) and lnd * SiMe 2 CI (1 .00 g, 3.40 mmol) were dissolved in THF (50 mL) cooled to 5 °C (ice/water bath). The solution was stirred for 2 h at 23 °C, then dried, and the product extracted in 2 χ 20 mL of pentane and dried to yield Me2 SB( R N,l * )H 2 as an oil in a quantitative yield.
Scheme 3 - Preparation of Me2 SB( R NJ * )H P liqand from lnd * SiMe ? CI
[00131] Figures 7, 8, 9 and 10 respectively show the 1 H NMR spectra for the ligands
Me2 SB( iPr N,l * )H 2 , Me2 SB( nBu N,l * )H 2 , Me2 SB( 4tBuPh N,l * )H 2 and Me2 SB( 4nBuPh N,l * )H 2 . [00132] Following the preparation of the proligand Me2 SB( R N,l * )H 2 , the Me2 SB( R N,r)TiCI 2 CGC was synthesised according to the procedure shown in Scheme 4: 2.2 equivalents of "BuLi (3.0 mL, 6.7 mmol, 2.5 M in hexanes) was added dropwise to a solution of Me2 SB( R N, )H 2 in 30 mL of THF cooled to 5 °C (water/ice bath). The solution darkened from yellow to orange and the reaction mixture was stirred for 30 minutes at 23 °C. The reaction mixture was then dried under vacuum, and the solid product was washed with pentane (2 x 25 mL) and dried to yield a yellow solid Me2 SB( R N, )Li 2 . 40 mL of benzene was added to a Schlenk containing 1 equivalent of Me2 SB( R N,l * )Li 2 (Ft= iPr (0.35 g, 1 .07 mmol), nBu (0.56 g, 1 .65 mmol), 4-tBuPh (1 .00 g, 2.40 mmol), 4-nBuPh (1 .00 g, 2.40 mmol)) and 1 equivalent of TiCI 4 .2THF (0.36 g, 0.55 g, 0.80 g, 0.80 g respectively). The solution turned a dark red and was stirred for 23 h. The reaction mixture was then dried under vacuum, and the product was extracted in pentane. The pentane solution was placed in a - 30 °C freezer and a red solid was afforded in all cases. Me2 SB( iPr N,l * )TiCI 2 was isolated in a 5.3% yield (79 mg), Me2 SB( nBu N,l * )TiCI 2 in a 6.5% yield (102 mg), Me2 SB( 4 tBuPh N,l * )TiCI 2 in a 28% yield (360 mg), and Me2 SB( 4 nBuPh N,l * )TiCI 2 in a 21 % yield (280 mg).
Scheme 4 - Preparation of Me2 SB( R N.r)TiCI ? CGCs from SB( N.DH?
[00133] Figures 1 1 , 12, 13, 14, and 15 respectively show the Ή NMR spectra for the CGCs
Me2 SB( iPr N,l * )TiCI 2 , Me2 SB( nBu N,l * )TiCI 2 , Me2 SB( 4tBuPh N,l * )TiCI 2 , Me2 SB( 4nBuPh N,l * )TiCI 2 and Me2 SB( tBu N,l * )ZrCI 2 . Figures 16 and 17 respectively show the molecular structures of Me2 SB( iPr N,l * )TiCI 2 and Me2 SB( 4tBuPh N,l * )TiCI 2 .
Example 4 - Synthesis of methylaluminoxane-activated layered double hydroxide- supported CGCs
[00134] Toluene was added to 1 .0 equivalent LDH (Mg 3 AI-C0 3 ) and 0.5 equivalents MAO in a Schlenk tube and the mixture heated at 80 °C for two hours with swirling. The white solid was allowed to settle, the solution decanted and the product dried under vacuum to give the activated supports in quantitative yield. LDHMAO (250 mg, 1 .497 mmole) and Et2 SB( tBu N,l * )TiCI 2 (5.6 mg, 0.75 mol) were weighed into a Schlenk tube, toluene (40 mL) was added and the solution swirled at 60 °C for one hour. The coloured solid was allowed to settle and the clear, colourless solution decanted. The solid was dried in vacuo to give the product as a faintly coloured powder in quantitative yield. Isolated yield of 86%.
Example 5 - Further polymerisation studies
Slurry phase polymerisation
[00135] The ability of methylaluminoxane-activated layered double hydroxide-supported Me2 SB( tBu N,r)TiCI 2 (denoted LDHMAO- Me2 SB( tBu N,r)TiCI 2 ) to catalyse the polymerisation of ethylene in the slurry phase was compared with that of the comparator methylaluminoxane- activated layered double hydroxide-supported Me2 SB( tBu N,Cp * )TiCI 2 composition (denoted LDHMAO- Me2 SB( tBu N,Cp * )TiCI 2 ). The polymerisation conditions were 2 bar ethylene, 50 mL hexanes, 150 mg TIBA, 70 °C, 30 minutes. Figure 18 shows that the LDHMAO- Me2 SB( tBu N,l * )TiCI 2 composition of the invention is markedly more active than the comparator LDHMAO- Me2 SB( tBu N,Cp)TiCI 2 composition under identical polymerisation conditions. Moreover, figure 19 illustrates that the polyethylene obtained with the LDHMAO- Me2 SB( tBu N,l * )TiCI 2 composition of the invention has an overall better morphology than the polyethylene obtained with the comparator LDHMAO- Me2 SB( tBu N,Cp * )TiCI 2 composition.
Scale-up solution phase polymerisation
[00136] The ability of the Me2 SB( tBu N,l * )TiCI 2 CGC of the invention to polymerise ethylene in the solution phase under scaled-up conditions was assessed. The polymerisation conditions were 5 bar ethylene, 1500 mL hexanes, 70 °C, 30-60 minutes, 3-7 mg of Me2 SB( tBu N,l * )TiCI 2 . The percentage of hydrogen in the ethylene feed stream was varied. Figure 20 shows that Me2 SB( tBu N,l * )TiCI 2 exhibits very high activity in large scale solution phase ethylene polymerisation, in particular when the ethylene feed stream contains 1 % H 2 .
[00137] In a separate experiment, the ability of the Me2 SB( tBu N,l * )TiCI 2 CGC of the invention to copolymerise ethylene and 1 -hexene under scaled-up conditions was assessed. The copolymerisation conditions were 6 bar ethylene, 1500 mL hexanes, 80°C, 34 minutes, 3.3 or 7 mg of Me2 SB( tBu N,l * )TiCI 2 . The results are shown in Table 2 below. The Me2 SB( tBu N,l * )TiCI 2 CGC of the invention is seen to be active not only in ethylene homopolymerisation, but also in ethylene/1 -hexene copolymerisation. The Me2 SB( tBu N,l * )TiCI 2 CGC showed a good copolymerisation response towards low polymer density {d = 0.9189). Table 2. Scale up solution copolymerisation of ethylene/1 -hexene using Me2 SB( Bu N,l * )TiCl2. Copolymerisation conditions: 6 bar ethylene, 1500 mL hexanes, 80 °C, 34 minutes, 3.3 or 7 mg of Me2 SB( Bu N,l * )TiCI 2 .
[00138] While specific embodiments of the invention have been described herein for the purpose of reference and illustration, various modifications will be apparent to a person skilled in the art without departing from the scope of the invention as defined by the appended claims.